Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9990467rdf:typepubmed:Citationlld:pubmed
pubmed-article:9990467lifeskim:mentionsumls-concept:C0040300lld:lifeskim
pubmed-article:9990467lifeskim:mentionsumls-concept:C0004057lld:lifeskim
pubmed-article:9990467lifeskim:mentionsumls-concept:C0221102lld:lifeskim
pubmed-article:9990467lifeskim:mentionsumls-concept:C0033262lld:lifeskim
pubmed-article:9990467lifeskim:mentionsumls-concept:C1258071lld:lifeskim
pubmed-article:9990467lifeskim:mentionsumls-concept:C0242184lld:lifeskim
pubmed-article:9990467lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:9990467lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:9990467pubmed:issue1lld:pubmed
pubmed-article:9990467pubmed:dateCreated1999-4-13lld:pubmed
pubmed-article:9990467pubmed:abstractTextA series of regioisomeric derivatives of a 1-methylindole-4,7-dione were synthesised, substituted with a 2-acetoxybenzoate leaving group linked through the (indol-2-yl)methyl or (indol-3-yl)methyl (or propenyl) positions. Reductive elimination of the leaving group occurred from the (indol-3-yl)methyl derivatives but not the 2-substituted regioisomers, indicating that only the C-3 position may be utilised in bioreductively-activated drug delivery, which was demonstrated with an aspirin prodrug.lld:pubmed
pubmed-article:9990467pubmed:languageenglld:pubmed
pubmed-article:9990467pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9990467pubmed:citationSubsetIMlld:pubmed
pubmed-article:9990467pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9990467pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9990467pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9990467pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9990467pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9990467pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9990467pubmed:statusMEDLINElld:pubmed
pubmed-article:9990467pubmed:monthJanlld:pubmed
pubmed-article:9990467pubmed:issn0960-894Xlld:pubmed
pubmed-article:9990467pubmed:authorpubmed-author:WardmanPPlld:pubmed
pubmed-article:9990467pubmed:authorpubmed-author:NolanJJlld:pubmed
pubmed-article:9990467pubmed:authorpubmed-author:PatelK BKBlld:pubmed
pubmed-article:9990467pubmed:authorpubmed-author:StratfordI...lld:pubmed
pubmed-article:9990467pubmed:authorpubmed-author:StratfordM...lld:pubmed
pubmed-article:9990467pubmed:authorpubmed-author:NaylorM AMAlld:pubmed
pubmed-article:9990467pubmed:authorpubmed-author:MooreS GSGlld:pubmed
pubmed-article:9990467pubmed:authorpubmed-author:JaffarMMlld:pubmed
pubmed-article:9990467pubmed:authorpubmed-author:EverettS ASAlld:pubmed
pubmed-article:9990467pubmed:authorpubmed-author:UlhaqSSlld:pubmed
pubmed-article:9990467pubmed:issnTypePrintlld:pubmed
pubmed-article:9990467pubmed:day4lld:pubmed
pubmed-article:9990467pubmed:volume9lld:pubmed
pubmed-article:9990467pubmed:ownerNLMlld:pubmed
pubmed-article:9990467pubmed:authorsCompleteYlld:pubmed
pubmed-article:9990467pubmed:pagination113-8lld:pubmed
pubmed-article:9990467pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9990467pubmed:meshHeadingpubmed-meshheading:9990467-...lld:pubmed
pubmed-article:9990467pubmed:meshHeadingpubmed-meshheading:9990467-...lld:pubmed
pubmed-article:9990467pubmed:meshHeadingpubmed-meshheading:9990467-...lld:pubmed
pubmed-article:9990467pubmed:meshHeadingpubmed-meshheading:9990467-...lld:pubmed
pubmed-article:9990467pubmed:meshHeadingpubmed-meshheading:9990467-...lld:pubmed
pubmed-article:9990467pubmed:meshHeadingpubmed-meshheading:9990467-...lld:pubmed
pubmed-article:9990467pubmed:meshHeadingpubmed-meshheading:9990467-...lld:pubmed
pubmed-article:9990467pubmed:meshHeadingpubmed-meshheading:9990467-...lld:pubmed
pubmed-article:9990467pubmed:meshHeadingpubmed-meshheading:9990467-...lld:pubmed
pubmed-article:9990467pubmed:meshHeadingpubmed-meshheading:9990467-...lld:pubmed
pubmed-article:9990467pubmed:meshHeadingpubmed-meshheading:9990467-...lld:pubmed
pubmed-article:9990467pubmed:meshHeadingpubmed-meshheading:9990467-...lld:pubmed
pubmed-article:9990467pubmed:meshHeadingpubmed-meshheading:9990467-...lld:pubmed
pubmed-article:9990467pubmed:year1999lld:pubmed
pubmed-article:9990467pubmed:articleTitleProdrugs for targeting hypoxic tissues: regiospecific elimination of aspirin from reduced indolequinones.lld:pubmed
pubmed-article:9990467pubmed:affiliationSchool of Pharmacy, University of Manchester, UK.lld:pubmed
pubmed-article:9990467pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9990467pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed